AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05663073 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irbesartan
Description: Co-administration of Irbesartan and Amlodipine
Study NCT05663073 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amlodipine
Description: Co-administration of Irbesartan and Amlodipine
Study NCT05626400 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Senl-T7
Description: Patients will be treated with CD7 CAR-T cells
Study NCT05952141 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Clinic Outreach
Description: A member of the pathology team will contact the referring clinic to communicate the readiness of results.
Study NCT05952141 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced Outreach
Description: A member of the pathology team will contact both the referring clinic and the patient directly to communicate the readiness of results.
Study NCT05952141 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low-Touch Strategy
Description: Patient will be sent asynchronous text messaging reminders related to the importance of timely care using framed messaging.
Study NCT05952141 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High-Touch Strategy
Description: Patient will be sent asynchronous text messaging reminders related to the importance of timely care using framed messaging in combination with synchronous telephone-based patient navigation.
Study NCT05565781 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ECG smartwatch
Description: Testing ECG smartwatch
Study NCT05565781 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Insertable Cardiac Monitor (ICM)
Description: Gold-standard cardiac monitor for comparison of testing device (ECG smartwatch)
Study NCT05565781 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: External ECG Monitoring
Description: Regular cardiac monitor for diagnosis of atrial fibrillation
Study NCT05565781 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: External ECG Monitoring
Description: Regular cardiac monitor for diagnosis of atrial fibrillation
Study NCT06440239 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PMS-101
Description: PMS-101
Study NCT06440239 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard treatment
Description: Standard treatment according to physicians
Study NCT05661877 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: DengueAid mobile application
Description: •Education materials regarding dengue fever and self-care. The education section (My Dengue Knowledge) consists of seven modules (dengue essentials, risk, symptoms, aedes mosquito, self-care, prevention and interesting facts) with gamification properties. Each module contains a series of multiple-choice questions. After answering each question, the user would be instantly notified if they had answered the question correctly and be provided with some facts related to the question. A progress meter would allow users to keep track of each module answered. A medal would be awarded to users who have completed 100% of each module. The self-care section consists of basic information about dengue fever and points to look out for self-care. It contains information on dengue fever phases, signs of dengue, importance of keeping hydrated, complementary therapy, medicine to avoid and prevention practices.
Study NCT05661877 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: MyHealth website
Description: MyHealth is developed by Ministry of Health, Malaysia (http://www.myhealth.gov.my/en/dengue-fever/) to provide information on dengue.
Study NCT06405776 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lidocaine
Description: Patients in the lidocaine group, lidocaine 1.5mg/kg/h is continuously infused (using ideal body weight) during the whole procedure, postoperative analgesia pump with lidocaine (lidocaine 50mg/kg, sufentanil 2ug/kg, glassetron 12mg) diluted to 200ml with saline until 72h after surgery.
Study NCT05136105 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Preventive Narrative Exposure Therapy (PreNET) family intervention
Description: Sessions: (1) Participants are invited to narrate the event in detail, in line with the protocol of the trauma-focused intervention NET. Furthermore, participants and caregiver(s) will receive a brief psychoeducation about expected symptoms and supportive behaviour in the aftermath of sexual violence.~(2) Two weeks after session 1, the second session focuses on caregiver only and their emotions. The narration of the event is read to the caregiver(s). Caregiver(s) receive assistance regulating their emotions. They receive psychoeducation on how to support their child.~(3) Two weeks after the second session, the children assisted by their caregivers lay a chronological lifeline of their most important life experiences. The chronology and the context of the traumatic events is reinforced. The narration of the sexual abuse is read again to the child and the caregiver(s). The caregiver(s) are encouraged to support emotionally their child during the renarration.
Study NCT05271409 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Satralizumab
Description: Study drug will be administered by SC injection in the abdominal or femoral region after all other study-related procedures have been performed at a site visit.
Study NCT05271409 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered by SC injection in the abdominal or femoral region after all other study-related procedures have been performed at a site visit.
Study NCT06370598 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TP-122A
Description: Bacteriophage cocktail targeting Psa
Study NCT06100627 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AP301
Description: Orally administered
Study NCT06405776 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: In the placebo group, the same volume of normal saline will be administered during anesthesia. The postoperative PCIA device will contain sufentanil 2μg/kg, granisetron 12mg diluted to 200 mL in 0.9% normal saline solution with a total volume of 200 mL.
Study NCT05334693 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Expanded haploidentical NK cells
Description: Two doses of expanded haploidentical NK cells (30-100 x 10\^6 cells /kg).
Study NCT04917159 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ACT (Acceptance and Commitment Therapy) plus brief CHF education
Description: The participants will identify their values and clarify their alternative behavior, exploring their thoughts and feelings, and finding ways to meet their own and their family member's needs. The rational bond between the patient and his/her family caregiver will be emphasized. In addtion, the contents of brief CHF education are based on the latest national clinical practice guideline for CHF, including symptoms monitoring, medication adherence, fluid and salt restriction, smoking cessation, alcohol consumption, and physical activity maintenance.
Study NCT04917159 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: HE (Health Education)
Description: The educational contents are based on the latest national clinical practice guideline for CHF. Besides the basic information on CHF education provided in intervention group, the contents of CHF education also include definition of CHF, epidemiology, diagnosis, comorbidity, and CHF treatment. ACT components are not covered.
Study NCT05978050 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nimotuzumab plus paclitaxel
Description: Nimotuzumab injection: 50mg/10ml/stick Paclitaxel: 30mg/5ml/stick
Study NCT05978050 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo plus paclitaxel
Description: placebo: 50mg/10ml/stick Paclitaxel: 30mg/5ml/stick
Study NCT06572059 — intervention group
Intervention type: OTHER
Intervention: assesments for once
Description: * EDSS score (patient reports recorded in the physician's record will be used.)~* Demographic information~* Fatigue Severity Scale (FSS)~* Beck Depression Inventory (BDI)~* Kinesthetic and Visual Imagery Questionnaire (KSVI)~* Mental Chronometer Test (Nine-Hole Peg Test (DDPT)) will be used.)~* Jebson-Taylor Hand Function Test (JHEFT)~* Manual Ability Test (MAM-36)~* Multiple Sclerosis Impact Scale (MSIS-29)
Study NCT06571721 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Topical Product: Almond Oil
Description: 1-2 Drops of randomized topical product will be applied on entire face nightly.
Study NCT06571721 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Topical Product: Almond oil augmented with 0.5% Vitamin E
Description: 1-2 Drops of randomized topical product will be applied on entire face nightly.
Study NCT04778527 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dual Prevention Pill
Description: a single over-encapsulated DPP containing a PrEP tablet and a COC
Study NCT04778527 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PrEP tablet and a COC as two separate tablets
Description: PrEP tablet and a COC as two separate tablets
Study NCT05958277 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin B3
Description: Vitamin B3 upto 16 mg/day
Study NCT05958277 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin B12
Description: Vit B12 upto 250 mcg per day
Study NCT05416658 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Antipsychotic Medication Decision Aid (APM-DA)
Description: The APM-DA intervention is the first and only International Patient Decision Aid Standards (IPDAS) approved shared decision making (SDM) decision aid intervention for Antipsychotic Medication decisions in psychiatric visits. The APM-DA intervention developed by the research team addresses a common issue among psychiatric care providers and patients that lies in the heart of pharmacotherapy - taking, tapering or stopping APM. The APM-DA has a print format and can be used online as a PDF. It includes a concise table describing what each option involves, its benefits, risks, and strategies to reduce risks. The intervention was developed in co-production with various stakeholders (patients, clinicians, service leadership, family members, researchers). Additional intervention materials are an evidence document to support the information and an APM side effects table.
Study NCT05435612 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: cochlear implant
Description: Patients enrolled in the study undergo the cochlear implant surgery.
Study NCT06667115 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: PNF exercise
Description: Foundational PNF D2 shoulder flexion exercise incorporating shoulder flexion, abduction, and external rotation. This exercise was performed at a metronome-guided pace of 14 beats per minute to establish a consistent baseline.
Study NCT06667115 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: PNF exercise with virtual reality gaming
Description: Combined the PNF D2 shoulder flexion exercise with a virtual reality motion capture game (the U-Ball game).
Study NCT06667115 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: PNF with concurrent feedback
Description: PNF exercise with the addition of auditory concurrent feedback (Sword) which referenced the action of unsheathing a sword in a diagonal upward direction.
Study NCT06069622 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 24-hour ambulatory blood pressure
Description: 24-hour ambulatory blood pressure, blood, and urine will be obtained prior to semaglutide therapy and after 20 weeks of semaglutide therapy.
Study NCT06069622 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Intervention: Liberal salt diet
Description: Participants will be on a liberal salt (about 200 mEq sodium/day) diet for 7 days.
Study NCT06170827 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AIO-001
Description: AIO-001 Solution for SC injection.
Study NCT06571721 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Topical Product: 0.025% Tretinoin oil augmented with castor oil
Description: 1-2 Drops of randomized topical product will be applied on entire face nightly.
Study NCT06329856 — intervention group
Intervention type: BEHAVIORAL
Intervention: Administering of artificial hydration
Description: Administering of artificial hydration to terminal cancer patients
Study NCT06269926 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Chronic Pain
Description: Treatment for chronic pain that addresses the relationship between thoughts, feelings and behaviors.
Study NCT06269926 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pain education
Description: A booklet on chronic pain (in this study, an educational pamphlet from the Oregon state health department) that provides pain education in addition to usual medical care.
Study NCT06670209 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GZR18 and metformin
Description: GZR18: 3 mg-18 mg Metformin: 500 mg
Study NCT06669845 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Ultrasonography, Pelvic
Description: Ultrasound measurements will be taken before and after bladder emptying. The axes of the uterine body, cervix and vagina will be marked out by tracing the 3 corresponding lines on the image.
Study NCT06669273 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CEST MRI sequence at 3T
Description: The MRI will be performed at the Clermont Ferrand University Hospital on the 3T research MRI on a Siemens MRI system (MAGNETOM VIDA, Siemens Healthcare, Erlangen, Germany), the emission of the radiofrequency pulses and the reception of the signal will be done using a coil dedicated to the abdo-pelvic region. The images will be analyzed by the radiologist.~MRI is non-irradiating medical imaging. It is practiced according to good practices and the recommendations of the French Society of Radiology.~* Acquisition of morphological T1, T2 sequences for the identification of areas of interest on the pelvic area.~* Acquisition of the CEST MRI sequence (acquisition time 5 min)~* Acquisition of functional sequences, DWI diffusion-weighted images and dynamic DCE sequence after injection of a single dose of non-linear gadolinum.~The imaging report will reveal the presence or absence of tumor lesions in the prostate and their location. Data will then be compared to the histopathological analysis.
Study NCT05399953 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial Release Technique
Description: Sternocleidomastoid, Upper trapezius, Suboccipital region, Scalenes, Pectoral release, Scapular and hyoid mobilization techniques.~Duration: 6 weeks, 1 supervised session per week, and the session lasted 30 minutes.
Study NCT05399953 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: Therapeutic exercise: passive and active range of motion, strengthening and postural exercise in order to improve shoulder and cervical mobility, muscle flexibility, strength and endurance, postural control and movement patterns; 2) stretching of pectoral muscles and serratus anterior; 3) scar tissue massage to reduce scar tissue's stiffness.~Duration of the intervention: 6 weeks (1 supervised session and 2 individual per week). Each exercise will be done 1-3 sets and 5-10 repetitions.The session lasted 30 minutes.~Exercise diary will be utilized in order to follow the exercise program.
Study NCT05399953 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Therapeutic exercise: passive and active range of motion, strengthening and postural exercise in order to improve shoulder and cervical mobility, muscle flexibility, strength and endurance, postural control and movement patterns; 2) stretching of pectoral muscles and serratus anterior; 3) scar tissue massage to reduce scar tissue's stiffness.~Duration of the intervention: 6 weeks (1 supervised session and 2 individual per week). Each exercise will be done 1-3 sets and 5-10 repetitions.The session lasted 30 minutes.~Exercise diary will be utilized in order to follow the exercise program.
Study NCT05399953 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Scar Tissue Massage
Description: Circular, Up and Down, Side to Side technique
Study NCT05399953 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scar Tissue Massage
Description: Circular, Up and Down, Side to Side technique
Study NCT06750614 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: intermittent theta-burst stimulation (iTBS)
Description: In each visit, the intensity of the iTBS applied to the participant will be set at 70% of their individual resting motor threshold (rMT), with one session specifically targeting the left DLPFC.
Study NCT06754969 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Peripheral Nerve Regenerative Interface (RPNI) and Nerve/Muscle Biopsy
Description: RPNI is a surgical technique which wraps denervated muscle targets around severed nerve ends.
Study NCT06754969 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biopsy Alone
Description: Sural nerve and muscle biopsy performed in the standard fashion.
Study NCT06777472 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: lung-benefiting moxibustion
Description: A kind of external treatment，the treatment theory is to treat winter diseases in summer.
Study NCT06777472 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: The specific drug comes from GINA (2024)
Description: Refer to GINA (2024).
Study NCT06777472 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: The specific drug comes from GINA (2024)
Description: Refer to GINA (2024).
Study NCT06775444 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Breastfeeding Education Program Based on Planned Behavior Theory
Description: In addition to routine breastfeeding training at the hospital where the study is conducted, the intervention group will be given a 2-session Breastfeeding Training Program Based on Planned Behavior Theory.~Education Content:~The importance of breast milk, the benefits of breastfeeding, the dangers of artificial feeding, putting the baby to the breast, signs of hunger in the baby, the harms of bottle and pacifier, breastfeeding positions, breast-related problems, information sources about breastfeeding, birth and breastfeeding leave for working mothers, breastfeeding in the community, the importance of environmental and professional support during breastfeeding. Insufficient milk anxiety, increasing milk intake and production, situations where milk should be expressed, milk expression methods, storage conditions of breast milk, alternative feeding methods with expressed milk, methods to be applied to increase breast milk, differences between breast milk and formula milk.
Study NCT06775444 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Routine Breastfeeding Training
Description: The control group will receive routine breastfeeding education at the hospital where the study is conducted. Routine breastfeeding education includes the importance of breast milk and breastfeeding (benefits of breast milk and breastfeeding, correct breastfeeding technique and breastfeeding positions, time for the first feeding of the newborn, feeding method, expressing and storing breast milk, techniques for giving expressed breast milk as close as possible to breastfeeding, harms of bottle use, breast problems and coping methods). Pregnant women who give birth at the hospital where the study is conducted receive routine breastfeeding education from the breastfeeding nurse in the ward before being discharged.
Study NCT06775509 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ortho-K
Description: Utilization of Ortho-K Contact Lenses for The Treatment of Myopia
Study NCT06776328 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Tools
Description: In the co-creation meetings, developed tools will be presented. Participants will be asked to provide feedback and input to tailor these tools to the needs and preferences of children and adolescents with suicidal thoughts/behavior.
Study NCT06776315 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Resistive threshold inspiratory muscle training device
Description: In the other arm of the study, respiratory muscle training is performed in addition to the standard pulmonary rehabilitation program. Respiratory muscle strengthening training is performed with a resistive thereshold inspiratory muscle strengthening device. The exercise is performed at an intensity of 30% of the maximum inspiratory pressure determined by mouth pressure measurement. The exercise is performed in 7 sets, with 2 minutes of work and 1 minute break for a total of 21 minutes.
Study NCT06776315 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard pulmonary rehabilitation programme
Description: Patients are asked to perform thoracic, diaphragmatic breathing, and lower basal breathing exercises with 10 repetitions. Then, strengthening exercises are performed on the major muscle groups of the upper and lower extremities. In accordance with the resistance training program in the ATS/ERS guidelines for pulmonary rehabilitation, two to four sets of 6-12 repetitions are performed with intensities ranging from 50% to 85% of one maximum repetition, two to three times a week. During the exercises, the patient is questioned about their fatigue and dyspnea levels using the Borg scale, and breaks are given when necessary. The aerobic exercise program is performed as a 12-week, 3-day-a-week self-walking exercise. The walking program is performed in the form of walking on flat ground at 60% workload, based on the data obtained from the 6-minute walking test result (land-based walking).
Study NCT06776315 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: No intervention
Description: Peripheral blood samples will be taken once from the participants in the control group and no other intervention will be performed.